Roche expands COVID testing portfolio with $1.8bn GenMark dealRoche has said it will pay $1.8 billion for molecular testing company GenMark, boosting the Swiss company’s diagnostic Share XRoche expands COVID testing portfolio with $1.8bn GenMark dealhttps://pharmaphorum.com/news/roche-expands-covid-testing-portfolio-with-1-8bn-genmark-deal/
Roche introduces 15-minute nasal COVID test in UKRoche Diagnostics has launched a 15-minute nasal antigen test for COVID-19 in the UK, and says it has Share XRoche introduces 15-minute nasal COVID test in UKhttps://pharmaphorum.com/news/roche-introduces-15-minute-nasal-covid-test-in-uk/
Roche on COVID-19 healthcare and testing: the pharmaphorum podcastFor episode 30 I spoke with Dr Ashton Harper, who’s head of medical affairs in the UK and Share XRoche on COVID-19 healthcare and testing: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/roche-covid-health-testing/
UK government backs five new AI health projectsThe UK government has backed five new centres for artificial intelligence (AI) in health, focusing on areas including Share XUK government backs five new AI health projectshttps://pharmaphorum.com/news/uk-government-backs-five-new-ai-health-projects/
Aiming to dominate in digital medicine, Roche and GE combine forcesDoctors and healthcare teams have a growing array of clinical tests and data sources to help guide their Share XAiming to dominate in digital medicine, Roche and GE combine forceshttps://pharmaphorum.com/news/aiming-dominate-digital-medicine-roche-ge-combine-forces/
